Request Legal Help Now - Free


FDA Announces Safety Changes for Simvastatin

. By
Washington, DCThe US Food and Drug Administration (FDA) has announced a change in the safety label for simvastatin (sold under the brand-name Zocor) because high-dose simvastatin has been linked to an increased risk of myopathy. The FDA recommends that 80 mg simvastatin, the highest dose approved by the FDA, only be used in patients who have already taken the dose for 12 months or more and have not developed muscle toxicity. Furthermore, the 80 mg simvastatin dose should not be prescribed to new patients.

Simvastatin is used to reduce the amount of bad cholesterol in the patient's blood. The FDA made its recommendations based on the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine clinical trial, which showed that patients taking 80 mg simvastatin daily had an increased risk of muscle injury. The risk is highest during the first 12 months of treatment with high-dose simvastatin and has been linked to interactions between simvastatin and other medications.

Simvastatin is sold under the brand-name Zocor. When combined with ezetimibe, it is sold as Vytorin. When combined with niacin, it is sold as Simcor. Both Zocor and Vytorin will carry the new dose restrictions.


Zocor Legal Help

If you or a loved one have suffered losses in this case, please click the link below and your complaint will be sent to a drugs & medical lawyer who may evaluate your claim at no cost or obligation.


Posted by

I need an update on the information I sent to you in regards to the DEPROVERA SHOT that I was taking back in the 1990's. Where I did have many of the side effects that was noted on your web article as well as Dr notes as proof

Posted by

i need a up date on my case.


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Click to learn more about

Request Legal Help Now! - Free